Table 3

Crude and age-adjusted and sex-adjusted incidence rates of amyloidosis, in men

Year	Population*	SpA cohort					Non-SpA cohort
Year	Population*	Cases	Crude rate (/100,000/year)	Adjusted rate† (/100,000/year)	95% CI		Cases	Crude rate (/100,000/year)	Adjusted rate† (/100,000/year)	95% CI
1999	172 698	39	22.58	25.23	17.84	35.08	1	0.58	0.60	0.00	4.54
2000	174 765	40	22.89	24.94	17.75	34.59		0.00	0.00	–	–
2001	176 763	56	31.68	32.47	24.39	42.85	1	0.57	0.59	0.00	4.37
2002	180 809	45	24.89	26.46	19.23	35.94	1	0.55	0.66	0.00	4.41
2003	185 045	48	25.94	27.52	20.23	36.94	4	2.16	2.44	0.68	6.77
2004	188 736	47	24.90	27.03	19.82	36.31	1	0.53	0.41	0.00	3.52
2005	193 291	22	11.38	12.46	7.78	19.22	2	1.03	1.16	0.15	4.70
2006	196 663	25	12.71	14.49	9.34	21.65	1	0.51	0.55	0.00	3.62
2007	200 927	31	15.43	16.61	11.26	23.86		0.00	0.00	–	–
2008	204 416	28	13.70	14.89	9.90	21.73	4	1.96	2.28	0.64	6.05
2009	205 835	48	23.32	25.26	18.58	33.68	1	0.49	0.63	0.00	3.54
2010	206 415	43	20.83	22.37	16.20	30.27	2	0.97	1.12	0.15	4.15
2011	206 880	28	13.53	14.55	9.69	21.13	3	1.45	1.51	0.29	4.58
2012	206 612	29	14.04	14.71	9.85	21.21	2	0.97	1.06	0.15	3.88
2013	205 475	22	10.71	11.03	6.90	16.75	1	0.49	0.50	0.00	2.88
2014	204 569	18	8.80	8.92	5.30	14.12	9	4.40	4.44	2.05	8.43
2015	204 119	27	13.23	13.23	8.72	19.27	7	3.43	3.43	1.36	7.06
1999–2015	3 314 018	596	17.98	19.54			40	1.21	1.26

*Población estimada de SpA.22
†Adjusted by sex and age.
SpA, spondyloarthritis.